541400 — Zim Laboratories Cashflow Statement
0.000.00%
- IN₹3.34bn
- IN₹4.49bn
- IN₹3.79bn
- 75
- 34
- 23
- 39
Annual cashflow statement for Zim Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 154 | 210 | 354 | 236 | 180 |
| Depreciation | |||||
| Non-Cash Items | 100 | 59.8 | 46.9 | 60.5 | 123 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -93.5 | 61.5 | -200 | -294 | -92.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 319 | 492 | 375 | 163 | 412 |
| Capital Expenditures | -64.8 | -152 | -367 | -739 | -408 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 5.96 | 6.54 | 4.64 | 9.11 | 8.71 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -58.8 | -146 | -362 | -730 | -399 |
| Financing Cash Flow Items | -151 | -13.4 | -59.5 | -74.6 | -122 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -260 | -330 | 5.46 | 595 | -91 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.685 | 20.3 | 30 | 31.8 | -76.5 |